Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02D malaria vaccine in infants living in a malaria-endemic region

被引:0
|
作者
Salim Abdulla
Nahya Salim
Francisca Machera
Richard Kamata
Omar Juma
Mwanajaa Shomari
Sulende Kubhoja
Ali Mohammed
Grace Mwangoka
Thomas Aebi
Hassan Mshinda
David Schellenberg
Terrell Carter
Tonya Villafana
Marie-Claude Dubois
Amanda Leach
Marc Lievens
Johan Vekemans
Joe Cohen
W Ripley Ballou
Marcel Tanner
机构
[1] Bagamoyo Research and Training Centre of Ifakara Health Institute,
[2] Muhimbili University of Health and Allied Sciences,undefined
[3] Swiss Tropical and Public Health Institute,undefined
[4] Tanzania Commission for Science and Technology,undefined
[5] London School of Hygiene and Tropical Medicine,undefined
[6] PATH Malaria Vaccine Initiative,undefined
[7] GlaxoSmithKline Biologicals,undefined
[8] University of Basel,undefined
[9] Ifakara Health Institute,undefined
来源
Malaria Journal | / 12卷
关键词
RTS,S/AS02; Malaria; Infants; Immunogenicity; Safety; Efficacy; EPI;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naive adults
    Kester, Kent E.
    Heppner, D. Gray, Jr.
    Moris, Philippe
    Ofori-Anyinam, Opokua
    Krzych, Urszula
    Tornieporth, Nadia
    McKinney, Denise
    Delchambre, Martine
    Ockenhouse, Christian F.
    Voss, Gerald
    Holland, Carolyn
    Beckey, Jolie Palensky
    Ballou, W. Ripley
    Cohen, Joe
    VACCINE, 2014, 32 (49) : 6683 - 6691
  • [42] Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
    Thera, Mahamadou A.
    Doumbo, Ogobara K.
    Coulibaly, Drissa
    Diallo, Dapa A.
    Kone, Abdoulaye K.
    Guindo, Ando B.
    Traore, Karim
    Dicko, Alassane
    Sagara, Issaka
    Sissoko, Mahamadou S.
    Baby, Mounirou
    Sissoko, Mady
    Diarra, Issa
    Niangaly, Amadou
    Dolo, Amagana
    Daou, Modibo
    Diawara, Sory I.
    Heppner, D. Gray
    Stewart, V. Ann
    Angov, Evelina
    Bergmann-Leitner, Elke S.
    Lanar, David E.
    Dutta, Sheetij
    Soisson, Lorraine
    Diggs, Carter L.
    Leach, Amanda
    Owusu, Alex
    Dubois, Marie-Claude
    Cohen, Joe
    Nixon, Jason N.
    Gregson, Aric
    Takala, Shannon L.
    Lyke, Kirsten E.
    Plowe, Christopher V.
    PLOS ONE, 2008, 3 (01):
  • [43] A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in the Gambia
    Doherty, JF
    Pinder, M
    Tornieporth, N
    Carton, C
    Vigneron, L
    Milligan, P
    Ballou, WR
    Holland, CA
    Kester, KE
    Voss, G
    Momin, P
    Greenwood, BM
    McAdam, KPWJ
    Cohen, J
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (06): : 865 - 868
  • [44] Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
    Mensah, Victorine A.
    Roetynck, Sophie
    Kanteh, Ebrima K.
    Bowyer, Georgina
    Ndaw, Amy
    Oko, Francis
    Bliss, Carly M.
    Jagne, Ya Jankey
    Cortese, Riccardo
    Nicosia, Alfredo
    Roberts, Rachel
    D'Alessio, Flavia
    Leroy, Odile
    Faye, Babacar
    Kampmann, Beate
    Cisse, Badara
    Bojang, Kalifa
    Gerry, Stephen
    Viebig, Nicola K.
    Lawrie, Alison M.
    Clarke, Ed
    Imoukhuede, Egeruan B.
    Ewer, Katie J.
    Hill, Adrian V. S.
    Afolabi, Muhammed O.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [45] Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
    von Seidlein, Lorenz
    Hanboonkunupakarn, Borimas
    Jittamala, Podjanee
    Pongsuwan, Pongphaya
    Chotivanich, Kesinee
    Taming, Joel
    Hoglund, Richard M.
    Winterberg, Markus
    Mukaka, Mavuto
    Peerawaranun, Pimnara
    Sirithiranont, Pasathorn
    Doran, Zoe
    Ockenhouse, Christian F.
    Ivinson, Karen
    Lee, Cynthia
    Birkett, Ashley J.
    Kaslow, David C.
    Singhasivanon, Pratap
    Day, Nicholas P. J.
    Dondorp, Arjen M.
    White, Nicholas J.
    Pukrittayakamee, Sasithon
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (01) : 33 - 41
  • [46] Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
    Guinovart, Caterina
    Aponte, John J.
    Sacarlal, Jahit
    Aide, Pedro
    Leach, Amanda
    Bassat, Quique
    Macete, Eusebio
    Dobano, Carlota
    Lievens, Marc
    Loucq, Christian
    Ballou, W. Ripley
    Cohen, Joe
    Alonso, Pedro L.
    PLOS ONE, 2009, 4 (04):
  • [47] Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults
    Creech, C. Buddy
    Dekker, Cornelia L.
    Ho, Dora
    Phillips, Shanda
    Mackey, Sally
    Murray-Krezan, Cristina
    Pau, Maria Grazia
    Hendriks, Jenny
    Brown, Valerie
    Dally, Leonard G.
    Versteege, Isabella
    Edwards, Kathryn M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (12) : 2548 - 2557
  • [48] Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS, S/AS01E Malaria Vaccine Integrated Within an Expanded Program on Immunization Regimen A Phase II, Single-Center, Open, Controlled Trial in Infants in Malawi
    Witte, Desiree
    Cunliffe, Nigel A.
    Turner, Ann M.
    Ngulube, Edward
    Ofori-Anyinam, Opokua
    Vekemans, Johan
    Chimpeni, Philips
    Lievens, Marc
    Wilson, Trevor P.
    Njiram'madzi, Jenala
    Mendoza, Yolanda Guerra
    Leach, Amanda
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (05) : 483 - 491
  • [49] Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414 -: A randomized, placebo-controlled trial in Latin American infants
    Salinas, M
    Schael, IP
    Linhares, AC
    Palacios, GMR
    Guerrero, ML
    Yarzábal, JP
    Cervantes, Y
    Clemens, SC
    Damaso, S
    Hardt, K
    De Vos, B
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (09) : 807 - 816
  • [50] Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial
    Asante, Kwaku Poku
    Ansong, Daniel
    Kaali, Seyram
    Adjei, Samuel
    Lievens, Marc
    Badu, Lydia Nana
    Darko, Prince Agyapong
    Buabeng, Patrick Boakye Yiadom
    Boahen, Owusu
    Rettig, Theresa Maria
    Agutu, Clara
    Harrison, Samuel Benard Ekow
    Ntiamoah, Yaw
    Anim, Japhet Adomako
    Adeniji, Elisha
    Dornudo, Albert Agordo
    Gvozdenovic, Emilia
    Dosoo, David
    Sambian, David
    Owusu-Boateng, Harry
    Wilson, Elvis Ato
    Prempeh, Frank
    Vandoolaeghe, Pascale
    Schuerman, Lode
    Owusu-Agyei, Seth
    Agbenyega, Tsiri
    Ofori-Anyinam, Opokua
    VACCINE, 2020, 38 (18) : 3411 - 3421